Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (241-250 of 596) with videos related to

Pageof 60
Sort By:
Connecticut Medicine|June 14, 2003
Role of pharmacodynamics in designing dosage regimens for beta-lactamsSrividya Kotapati, Joseph L Kuti, Charles H Nightingale, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 8, 2008
A prospective randomized clinical trial of urethral catheter removal following elective cesarean deliveryT G Onile, O Kuti, Ernest O Orji, et al.
Journal of Medical Microbiology|August 23, 2008
Influence of automated screening and confirmation of extended-spectrum beta-lactamase-producing members of the Enterobacteriaceae on prescribing of antibioticsAnthony M Nicasio, Joseph L Kuti, Jaber Aslanzadeh, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysisDora E Wiskirchen, Ashley Shepard, Joseph L Kuti, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureusMao Hagihara, Dora E Wiskirchen, Joseph L Kuti, et al.
Journal of Neurosciences in Rural Practice|January 12, 2016
Epidemiological, clinical and prognostic profile of childhood acute bacterial meningitis in a resource poor settingBankole Peter Kuti, Emmanuel Olasehinde Bello, Tolulope Opeoluwa Jegede, et al.
The Annals of Pharmacotherapy|February 6, 2009
Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistanceJared L Crandon, Joseph L Kuti, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002Carlos R V Kiffer, Caio Mendes, Joseph L Kuti, et al.
Pharmacotherapy|January 27, 2004
Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosaJoseph L Kuti, Naomi R Florea, Charles H Nightingale, et al.
Clinical Therapeutics|March 7, 2020
Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric DevicesIris H Chen, Elizabeth K Martin, David P Nicolau, et al.
Pageof 60

Showing results (241-250 of 596) with videos related to

Sort By:
Pageof 60
Connecticut Medicine|June 14, 2003
Role of pharmacodynamics in designing dosage regimens for beta-lactamsSrividya Kotapati, Joseph L Kuti, Charles H Nightingale, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 8, 2008
A prospective randomized clinical trial of urethral catheter removal following elective cesarean deliveryT G Onile, O Kuti, Ernest O Orji, et al.
Journal of Medical Microbiology|August 23, 2008
Influence of automated screening and confirmation of extended-spectrum beta-lactamase-producing members of the Enterobacteriaceae on prescribing of antibioticsAnthony M Nicasio, Joseph L Kuti, Jaber Aslanzadeh, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysisDora E Wiskirchen, Ashley Shepard, Joseph L Kuti, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureusMao Hagihara, Dora E Wiskirchen, Joseph L Kuti, et al.
Journal of Neurosciences in Rural Practice|January 12, 2016
Epidemiological, clinical and prognostic profile of childhood acute bacterial meningitis in a resource poor settingBankole Peter Kuti, Emmanuel Olasehinde Bello, Tolulope Opeoluwa Jegede, et al.
The Annals of Pharmacotherapy|February 6, 2009
Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistanceJared L Crandon, Joseph L Kuti, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002Carlos R V Kiffer, Caio Mendes, Joseph L Kuti, et al.
Pharmacotherapy|January 27, 2004
Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosaJoseph L Kuti, Naomi R Florea, Charles H Nightingale, et al.
Clinical Therapeutics|March 7, 2020
Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric DevicesIris H Chen, Elizabeth K Martin, David P Nicolau, et al.
Pageof 60